Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllocles tumor of the prostate

被引:46
作者
McCarthy, RP
Zhang, SB
Bostwick, DG
Qian, JQ
Eble, JN
Wang, MS
Lin, HQ
Cheng, L
机构
[1] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46204 USA
[2] Indiana Univ, Sch Med, Dept Lab Med, Indianapolis, IN 46204 USA
[3] Bostwick Labs, Richmond, VA USA
[4] Yale Univ, Dept Biostat, New Haven, CT USA
关键词
D O I
10.1016/S0002-9440(10)63397-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Phyllodes tumor of the prostate is a rare neoplasm, composed of epithelium-lined cysts and channels embedded in a variably cellular stroma. The pathogenetic relationship of the epithelium and stroma is unknown and whether each is a clonal neoplastic element is uncertain. We studied the clonality of phyllodes tumors from six patients who under-went either enucleation or transurethral resection as their initial treatment. This was followed by total prostatectomy in three of the patients. Laser-assisted microdissection was performed to extract epithelial and stromal components of phyllodes; tumor from formalin-fixed, paraffin-embedded tissue. Polymerase chain reaction was used to amplify genomic DNA at specific loci on chromosome 7q31 (D7S522), 8p21.3-q11.1 (D8S133, D8S137), 8p22 (D8S261), 10q23 (D10S168, D10S571), 17p13 (TP53), 16q23.2 (D16S507), 12q11-12 (D12S264), 17q (D17S855), 18p11.22-p11 (D18S53), and 22q11.2 (D22S264). In each tumor, stroma and epithelium were analyzed separately. Gel electrophoresis with autoradiography was used to detect loss of heterozygosity. All tumors showed allelic loss in one or more loci of both the epithelial and stromal components. The frequency of allelic loss in the epithelial component was 2 of 5 (40%) at D7S522, 2 of 6 (33%) at D8S133, 1 of 5 (20%) at D8S137, 3 of 6 (50%) at D8S261, 4 of 4 (100%) at D10S168, 4 of 6 (67%) at TP53, 2 of 6 (33%) at D10S571, 6 of 6 (100%) at D16S507, I of 5 (20%) at D12S264, I of 6 (17%) at D17S855, 2 of 6 (33%) at D18S53, and 2 of 5 (40%) at D22S264. The frequency of allelic loss in the stromal. component was 2 of 5 (40%) at D7S522, I of 6 (17%) at D8S133, 2 of 5 (40%) at D8S137, 3 of 6 (50%) at D8S261, 1 of 4 (25%) at D10S168, 3 of 6 (50%) at TP53, 2 of 6 (33%) at D10S571, 3 of 6 (50%) at D16S507, 1 of 5 (20%) at D12S264, 0 of 6 (0%) at D17S855, 1 of 6 (17%) at D18S53, and 0 of 5 (0%) at D22S264. The pattern of allelic loss is significantly different in both stroma and epithelium statistically; completely concordant affelic loss patterns were not seen in any tumor examined. Our data demonstrate that both epithelial and stromal components of phyllodes tumor of the prostate are clonal, supporting the hypothesis that both elements are neoplastic. While both epithelium and stroma are clonal proliferations, they appear to have different clonal. origins.
引用
收藏
页码:1395 / 1400
页数:6
相关论文
共 47 条
  • [1] AHOMADEGBE JC, 1995, ONCOGENE, V10, P1217
  • [2] PHYLLODES TYPE OF ATYPICAL PROSTATIC HYPERPLASIA
    ATTAH, EB
    NKPOSONG, EO
    [J]. JOURNAL OF UROLOGY, 1976, 115 (06) : 762 - 764
  • [3] Cell sampling - Laser capture microdissection: Molecular analysis of tissue
    Bonner, RF
    EmmertBuck, M
    Cole, K
    Pohida, T
    Chuaqui, R
    Goldstein, S
    Liotta, LA
    [J]. SCIENCE, 1997, 278 (5342) : 1481 - &
  • [4] BOOKSTEIN R, 1993, CANCER RES, V53, P3369
  • [5] BOSTWICK DG, 1998, CANCER, V83, P19995
  • [6] Brandli DW, 2003, CANCER RES, V63, P6063
  • [7] Brooks JD, 1996, CANCER RES, V56, P3814
  • [8] Cacic M, 1996, SCAND J UROL NEPHROL, V30, P501
  • [9] IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE IN CLINICAL ONCOLOGY
    CHANG, FJ
    SYRJANEN, S
    SYRJANEN, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 1009 - 1022
  • [10] Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder
    Cheng, L
    MacLennan, GT
    Zhang, SB
    Wang, MS
    Pan, CX
    Koch, MO
    [J]. CANCER, 2004, 101 (01) : 183 - 188